Markers of metabolic disease (i.e., dyslipidemia, dysglycemia and systemic inflammation) were measured pre and post intervention, including bloods lipids, hemoglobin A1c, and C-reactive protein. This evidence concerns the gene CRP and Other metabolic disease.